In cancer, EMT has been initially considered as a binary process with two very distinct cell populations - epithelial and mesenchymal, characterized by the loss of expression of the epithelial marker E-cadherin and the gain of the expression of the mesenchymal markers N-cadherin and vimentin [37]. The gene discussed is CDH2; the disease is cancer.